NCT02900261 is a clinical trial of No intervention in Sodium, sponsored by University of Lausanne Hospitals.

Who is sponsoring NCT02900261?

NCT02900261 is sponsored by University of Lausanne Hospitals.

What drugs are being tested in NCT02900261?

Interventions in NCT02900261: No intervention.

What condition does NCT02900261 study?

NCT02900261 studies Sodium, Caffeine.

Is NCT02900261 still recruiting?

NCT02900261 is currently completed. Last updated 20 April 2018.

Last reviewed 2018-04-20 · How we verify

NCT02900261

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Study on Sodium and Caffeine in Children and Adolescents

Completed Last updated 20 April 2018

What this trial tests

trial testing No intervention in Sodium in 101 participants. Completed in 18 February 2018.

Timeline

28 September 2016

Primary endpoint
18 February 2018

18 February 2018

Quick facts

Lead sponsor	University of Lausanne Hospitals
Status	Completed
Study type	OBSERVATIONAL
Enrollment	101
Start date	28 September 2016
Primary completion	18 February 2018
Estimated completion	18 February 2018
Sites	1 location across Switzerland

Drugs / interventions tested

No intervention

Conditions studied

Sodium — all drugs for Sodium →
Caffeine — all drugs for Caffeine →

Sponsor

University of Lausanne Hospitals

Who can join

Adults 6 to 16, any sex, with Sodium or Caffeine. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study will compare different methods (24 hour urine collection, evening and morning spots, and questionnaires) to measure the consumption of sodium and cafeine in children and adolescents.

Publications & conference data

4 peer-reviewed publications reference this trial (live from Europe PMC):

Urine Spot Samples Can Be Used to Estimate 24-Hour Urinary Sodium Excretion in Children.
Rios-Leyvraz M, Bovet P, Tabin R, Genin B, et al · · 2018 · cited 16× · PMID 30517722 · DOI 10.1093/jn/nxy211
Spot urine samples to estimate 24-hour urinary calcium excretion in school-age children.
Paccaud Y, Rios-Leyvraz M, Bochud M, Tabin R, et al · · 2020 · cited 12× · PMID 32388721 · DOI 10.1007/s00431-020-03662-z
Monitoring caffeine intake in children with a questionnaire and urine collection: a cross-sectional study in a convenience sample in Switzerland.
Rios-Leyvraz M, Bochud M, Tabin R, Genin B, et al · · 2020 · cited 11× · PMID 32016643 · DOI 10.1007/s00394-020-02187-3
Estimation of salt intake and excretion in children in one region of Switzerland: a cross-sectional study.
Rios-Leyvraz M, Bovet P, Bochud M, Genin B, et al · · 2019 · cited 11× · PMID 30341681 · DOI 10.1007/s00394-018-1845-4

Verify or expand the search:

Other trials of No intervention

Trials testing the same drug.

NCT06643052 — Cahnge in Management of Suspected Early Onset Neonetal Sepsis After Assimilation of Early Onset Sepsis Calculator · not yet recruiting
NCT07540611 — Gonadotropin Therapy in Idiopathic Hypogonadal Non-Obstructive · NA · not yet recruiting
NCT07291778 — Doppler Evaluation for Congestive Acute Kidney Injury in Critical Illness · NA · not yet recruiting
NCT07490431 — An Observational Study to Learn More About How Elinzanetant is Used and How Well it Works for Women With Menopause Sympt · not yet recruiting
NCT07515365 — Colitis Patterns in Patients With Lower GI Symptoms · not yet recruiting

Other University of Lausanne Hospitals trials

Trials by the same sponsor.

NCT06912906 — Feasibility Study to Compare Two Ventilatory Modes for Mechanical Ventilation Weaning · NA · not yet recruiting
NCT06482489 — Accurate Prostate Cancer Following Using Low-Field MRI (Low-PRISM) · recruiting
NCT06552832 — CAVEAT: An Open-Trial Feasibility Study · NA · recruiting
NCT05927324 — Clinician-Assisted Videofeedback Exposure-Approach Therapy (CAVEAT) Trial · NA · recruiting
NCT06320457 — A Brief Case Management Intervention for People Involuntarily Admitted to a Psychiatric Hospital · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT02900261 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Lausanne Hospitals
Last refreshed: 20 April 2018

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02900261.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing